|
|
- NHS Regional Offices
- NHS Foundation Trusts (England) - Medical Director
- NHS Trusts (England) - Medical Director
|
|
|
- MHRA (Medicines) Drug Alerts (Various Recipients)
- Other contacts
- Independent Healthcare Providers (registered with CAS)
- Clinical Commissioning Groups
- NHS Foundation Trusts (England) - Chief Executive
- MHRA (Medicines) Drug Alerts - Non-NHS Recipients
- Territorial CMOs in Northern Ireland, Scotland & Wales
- Regional Directors of Public Health
- Director of Public Health
- NHS Trusts (England) - Chief Executive
- GP - Locum
- NHS 111 and Out of hours providers
- Dispensing GP Practices
- DHSC Supply Disruption - Medicines
- Primary Care Networks
|
| Title: |
|
CLASS 4, DRUG ALERT, FOR INFORMATION, PFIZER LIMITED, ECALTA 100MG POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION
|
| Broadcast content: |
|
Pfizer Limited has informed us that the packs of the affected batches have not been packaged with the current version of the Patient Information Leaflet containing updated storage instructions of the infusion solution in Section 5.
Advice for healthcare professionals:
When dispensing this medicine from the affected batches listed, please ensure that the correct PIL is issued. The correct PIL is available from the electronic medicines compendium (EMC) website by clicking on the link below:
The Summary of Product Characteristics (SmPC Section 6.3) has been updated to state "The infusion solution may be stored at 25oC for 48 hours. Do not freeze."
Full details of the drug alert are included in the attached PDF file. Please forward to the listed recipients. This information is also published on the MHRA website https://www.gov.uk/drug-device-alerts
|
| Additional information: |
|
NHS England and NHS Improvement Regional Offices: please cascade this alert to Community Pharmacy contractors.
GP Practices: Please note this alert is for Dispensing GP Practices only.
|
| Cascade to: |
|
- #COMMUNITYPHARMACISTS#
- #DISPENSING GP#
- #HospitalPharmacy#
|